{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T15:17:06Z","timestamp":1784128626421,"version":"3.55.0"},"reference-count":59,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejinme.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Internal Medicine"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1016\/j.ejim.2025.106639","type":"journal-article","created":{"date-parts":[[2025,12,18]],"date-time":"2025-12-18T04:39:17Z","timestamp":1766032757000},"page":"106639","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Oral anticoagulant nonprescription at discharge in geriatric patients with atrial fibrillation and reduced expected survival"],"prefix":"10.1016","volume":"146","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2028-2319","authenticated-orcid":false,"given":"Enrico","family":"Brunetti","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6680-7681","authenticated-orcid":false,"given":"Roberto","family":"Presta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2969-7393","authenticated-orcid":false,"given":"Chukwuma","family":"Okoye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0194-142X","authenticated-orcid":false,"given":"Claudia","family":"Filippini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvio","family":"Raspo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerardo","family":"Bruno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Marabotto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1676-098X","authenticated-orcid":false,"given":"Fabio","family":"Monzani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela","family":"Sciacqua","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2945-0243","authenticated-orcid":false,"given":"Mario","family":"Bo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"36","key":"10.1016\/j.ejim.2025.106639_bib0001","doi-asserted-by":"crossref","first-page":"3314","DOI":"10.1093\/eurheartj\/ehae176","article-title":"2024 ESC guidelines for the management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS)","volume":"45","author":"Van Gelder","year":"2024","journal-title":"Eur Heart J"},{"issue":"10","key":"10.1016\/j.ejim.2025.106639_bib0002","doi-asserted-by":"crossref","first-page":"1612","DOI":"10.1093\/europace\/euab065","article-title":"2021 European heart rhythm association practical guide on the use of non-vitamin k antagonist oral anticoagulants in patients with atrial fibrillation","volume":"23","author":"Steffel","year":"2021","journal-title":"Europace"},{"issue":"1","key":"10.1016\/j.ejim.2025.106639_bib0003","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1161\/CIR.0000000000001193","article-title":"2023 ACC\/AHA\/ACCP\/HRS guideline for the diagnosis and management of atrial fibrillation: a report of the American college of cardiology\/American heart association joint committee on clinical practice guidelines","volume":"149","author":"Joglar","year":"2024","journal-title":"Circulation"},{"issue":"2","key":"10.1016\/j.ejim.2025.106639_bib0004","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1111\/jgs.16822","article-title":"Geriatric syndromes and atrial fibrillation: prevalence and association with anticoagulant use in a national cohort of older Americans","volume":"69","author":"Shah","year":"2021","journal-title":"J Am Geriatr Soc"},{"issue":"8","key":"10.1016\/j.ejim.2025.106639_bib0005","doi-asserted-by":"crossref","first-page":"2386","DOI":"10.1111\/jgs.17884","article-title":"Oral anticoagulants and outcomes in adults \u226580 years with atrial fibrillation: a global federated health network analysis","volume":"70","author":"Harrison","year":"2022","journal-title":"J Am Geriatr Soc"},{"key":"10.1016\/j.ejim.2025.106639_bib0006","doi-asserted-by":"crossref","DOI":"10.1111\/jgs.18375","article-title":"Initiation of oral anticoagulation in US older adults newly diagnosed with atrial fibrillation during hospitalization","author":"Troy","year":"2023","journal-title":"J Am Geriatr Soc"},{"key":"10.1016\/j.ejim.2025.106639_bib0007","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.ejim.2019.10.026","article-title":"Practical use of direct oral anti coagulants (DOACs) in the older persons with atrial fibrillation","volume":"71","author":"Bo","year":"2020","journal-title":"Eur J Intern Med"},{"issue":"1","key":"10.1016\/j.ejim.2025.106639_bib0008","first-page":"77","article-title":"The introduction of direct oral anticoagulants has not resolved treatment gaps for frail patients with nonvalvular atrial fibrillation","volume":"38","author":"Orlandi","year":"2022","journal-title":"Can J Cardiol"},{"issue":"3","key":"10.1016\/j.ejim.2025.106639_bib0009","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1093\/ageing\/afaa265","article-title":"Atrial fibrillation and oral anticoagulation in older people with frailty: a nationwide primary care electronic health records cohort study","volume":"50","author":"Wilkinson","year":"2021","journal-title":"Age Ageing"},{"key":"10.1016\/j.ejim.2025.106639_bib0010","doi-asserted-by":"crossref","DOI":"10.1016\/j.arr.2022.101761","article-title":"Impact of frailty models on the prescription of oral anticoagulants and on the incidence of stroke, bleeding, and mortality in older patients with atrial fibrillation: a systematic review","volume":"82","author":"Presta","year":"2022","journal-title":"Ageing Res Rev"},{"issue":"4","key":"10.1016\/j.ejim.2025.106639_bib0011","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1111\/jgs.16335","article-title":"Geriatric conditions predict discontinuation of anticoagulation in long-term care residents with atrial fibrillation","volume":"68","author":"Kapoor","year":"2020","journal-title":"J Am Geriatr Soc"},{"issue":"12","key":"10.1016\/j.ejim.2025.106639_bib0012","doi-asserted-by":"crossref","first-page":"2778","DOI":"10.1111\/jgs.16756","article-title":"Frailty, cognitive impairment, and anticoagulation among older adults with nonvalvular atrial fibrillation","volume":"68","author":"Mailhot","year":"2020","journal-title":"J Am Geriatr Soc"},{"issue":"12","key":"10.1016\/j.ejim.2025.106639_bib0013","doi-asserted-by":"crossref","first-page":"3503","DOI":"10.1111\/jgs.18001","article-title":"Frailty phenotype as a predictor of bleeding and mortality in ambulatory patients receiving direct oral anticoagulants","volume":"70","author":"Candeloro","year":"2022","journal-title":"J Am Geriatr Soc"},{"issue":"2","key":"10.1016\/j.ejim.2025.106639_bib0014","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1111\/jgs.18079","article-title":"Differential effect of anticoagulation according to cognitive function and frailty in older patients with atrial fibrillation","volume":"71","author":"Wang","year":"2023","journal-title":"J Am Geriatr Soc"},{"issue":"2","key":"10.1016\/j.ejim.2025.106639_bib0015","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1111\/jgs.18108","article-title":"Benefits and harms of oral anticoagulants for atrial fibrillation in nursing home residents with advanced dementia","volume":"71","author":"Ouellet","year":"2023","journal-title":"J Am Geriatr Soc"},{"issue":"3","key":"10.1016\/j.ejim.2025.106639_bib0016","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1093\/ageing\/afaa268","article-title":"Prevalence of atrial fibrillation and outcomes in older long-term care residents: a systematic review","volume":"50","author":"Ritchie","year":"2021","journal-title":"Age Ageing"},{"issue":"8","key":"10.1016\/j.ejim.2025.106639_bib0017","doi-asserted-by":"crossref","first-page":"afac192","DOI":"10.1093\/ageing\/afac192","article-title":"Epidemiology and impact of frailty in patients with atrial fibrillation in Europe","volume":"51","author":"Proietti","year":"2022","journal-title":"Age Ageing"},{"issue":"11","key":"10.1016\/j.ejim.2025.106639_bib0018","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2022.42964","article-title":"Trends in use of oral anticoagulants in older adults with newly diagnosed atrial fibrillation, 2010-2020","volume":"5","author":"Ko","year":"2022","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.ejim.2025.106639_bib0019","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.ejim.2017.03.012","article-title":"Oral anticoagulant therapy for older patients with atrial fibrillation: a review of current evidence","volume":"41","author":"Bo","year":"2017","journal-title":"Eur J Intern Med"},{"key":"10.1016\/j.ejim.2025.106639_bib0020","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.ijcard.2015.03.334","article-title":"Health status, geriatric syndromes and prescription of oral anticoagulant therapy in elderly medical in-patients with atrial fibrillation: a prospective observational study","volume":"187","author":"Bo","year":"2015","journal-title":"Int J Cardiol"},{"issue":"4","key":"10.1016\/j.ejim.2025.106639_bib0021","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1093\/eurheartj\/eht483","article-title":"Clinical course of atrial fibrillation in older adults: the importance of cardiovascular events beyond stroke","volume":"35","author":"Piccini","year":"2014","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ejim.2025.106639_bib0022","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.ejim.2021.01.020","article-title":"Long-term effectiveness and safety of anticoagulation therapy in oldest old, frail people with atrial fibrillation","volume":"86","author":"Calsolaro","year":"2021","journal-title":"Eur J Intern Med"},{"issue":"2","key":"10.1016\/j.ejim.2025.106639_bib0023","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1093\/ageing\/afy180","article-title":"Management of atrial fibrillation for older people with frailty: a systematic review and meta-analysis","volume":"48","author":"Wilkinson","year":"2019","journal-title":"Age Ageing"},{"key":"10.1016\/j.ejim.2025.106639_bib0024","doi-asserted-by":"crossref","DOI":"10.1016\/j.archger.2022.104661","article-title":"Frailty and outcomes in older adults with non-valvular atrial fibrillation from the ANAFIE registry","volume":"101","author":"Akishita","year":"2022","journal-title":"Arch Gerontol Geriatr"},{"issue":"8","key":"10.1016\/j.ejim.2025.106639_bib0025","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCOUTCOMES.123.010642","article-title":"Trajectories of frailty and clinical outcomes in older adults with atrial fibrillation: insights from the Shizuoka Kokuho Database","volume":"17","author":"Nakamaru","year":"2024","journal-title":"Circ Cardiovasc Qual Outcomes"},{"issue":"4","key":"10.1016\/j.ejim.2025.106639_bib0026","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1016\/j.amjcard.2015.11.032","article-title":"Effects of oral anticoagulant therapy in medical inpatients \u226565 years with atrial fibrillation","volume":"117","author":"Bo","year":"2016","journal-title":"Am J Cardiol"},{"issue":"3","key":"10.1016\/j.ejim.2025.106639_bib0027","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1111\/ggi.12730","article-title":"Health status, geriatric syndromes and prescription of oral anticoagulant therapy in elderly medical inpatients with atrial fibrillation","volume":"17","author":"Bo","year":"2017","journal-title":"Geriatr Gerontol Int"},{"issue":"1","key":"10.1016\/j.ejim.2025.106639_bib0028","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1007\/s41999-021-00537-w","article-title":"Atrial fibrillation: a geriatric perspective on the 2020 ESC guidelines","volume":"13","author":"Polidori","year":"2022","journal-title":"Eur Geriatr Med"},{"issue":"1","key":"10.1016\/j.ejim.2025.106639_bib0029","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1007\/s40520-024-02772-0","article-title":"The Italian guideline on comprehensive geriatric assessment (CGA) for the older persons: a collaborative work of 25 Italian Scientific Societies and the National Institute of Health","volume":"36","author":"Pilotto","year":"2024","journal-title":"Aging Clin Exp Res"},{"issue":"4","key":"10.1016\/j.ejim.2025.106639_bib0030","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1093\/europace\/euac123","volume":"25","author":"Savelieva","year":"2023","journal-title":"Europace"},{"issue":"4","key":"10.1016\/j.ejim.2025.106639_bib0031","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCOUTCOMES.123.010269","article-title":"Estimating vitamin K antagonist anticoagulation benefit in people with atrial fibrillation accounting for competing risks: evidence from 12 randomized trials","volume":"17","author":"Shah","year":"2024","journal-title":"Circ Cardiovasc Qual Outcomes"},{"issue":"4","key":"10.1016\/j.ejim.2025.106639_bib0032","first-page":"600","article-title":"Screening tool of older persons prescriptions in frail adults with limited life expectancy): consensus validation","volume":"46","author":"Lavan","year":"2017","journal-title":"Age Ageing"},{"issue":"3","key":"10.1016\/j.ejim.2025.106639_bib0033","doi-asserted-by":"crossref","DOI":"10.1016\/j.jamda.2024.01.011","article-title":"Predictors and outcomes of oral anticoagulant deprescribing in geriatric inpatients with atrial fibrillation: a retrospective multicenter cohort study","volume":"25","author":"Brunetti","year":"2024","journal-title":"J Am Med Dir Assoc"},{"issue":"4","key":"10.1016\/j.ejim.2025.106639_bib0034","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/j.jclinepi.2007.11.008","article-title":"The strengthening the reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies","volume":"61","author":"von Elm","year":"2008","journal-title":"J Clin Epidemiol"},{"issue":"2","key":"10.1016\/j.ejim.2025.106639_bib0035","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1378\/chest.09-1584","article-title":"Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the euro heart survey on atrial fibrillation","volume":"137","author":"Lip","year":"2010","journal-title":"Chest"},{"issue":"2","key":"10.1016\/j.ejim.2025.106639_bib0036","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.jacc.2010.09.024","volume":"57","author":"Lip","year":"2011","journal-title":"J Am Coll Cardiol"},{"issue":"5","key":"10.1016\/j.ejim.2025.106639_bib0037","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/0021-9681(87)90171-8","article-title":"A new method of classifying prognostic comorbidity in longitudinal studies: development and validation","volume":"40","author":"Charlson","year":"1987","journal-title":"J Chronic Dis"},{"issue":"1","key":"10.1016\/j.ejim.2025.106639_bib0038","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1093\/geront\/10.1_Part_1.20","article-title":"Progress in development of the index of ADL","volume":"10","author":"Katz","year":"1970","journal-title":"Gerontologist"},{"issue":"3","key":"10.1016\/j.ejim.2025.106639_bib0039","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1093\/geront\/9.3_Part_1.179","article-title":"Assessment of older people: self-maintaining and instrumental activities of daily living","volume":"9","author":"Lawton","year":"1969","journal-title":"Gerontologist"},{"issue":"10","key":"10.1016\/j.ejim.2025.106639_bib0040","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1111\/j.1532-5415.1975.tb00927.x","article-title":"A short portable mental status questionnaire for the assessment of organic brain deficit in elderly patients","volume":"23","author":"Pfeiffer","year":"1975","journal-title":"J Am Geriatr Soc"},{"issue":"3","key":"10.1016\/j.ejim.2025.106639_bib0041","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1214\/aos\/1176350951","article-title":"A class of K-sample tests for comparing the cumulative incidence of a competing risk","volume":"16","author":"Gray","year":"1988","journal-title":"Ann Stat"},{"key":"10.1016\/j.ejim.2025.106639_bib0042","unstructured":"Ene M., Leighton E.A., Blue G.L., Bell B. Multilevel models for categorical data using SAS \u00ae PROC GLIMMIX: the basics. In: 2014. Accessed May 27, 2023. https:\/\/www.semanticscholar.org\/paper\/Multilevel-Models-for-Categorical-Data-using-SAS-%C2%AE-Ene-Leighton\/da6cfa309c608466633ce38e6ae392d9cb8add14."},{"issue":"6","key":"10.1016\/j.ejim.2025.106639_bib0043","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1002\/(SICI)1097-0258(19990330)18:6<695::AID-SIM60>3.0.CO;2-O","article-title":"Estimation of failure probabilities in the presence of competing risks: new representations of old estimators","volume":"18","author":"Gooley","year":"1999","journal-title":"Stat Med"},{"issue":"1","key":"10.1016\/j.ejim.2025.106639_bib0044","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1111\/jgs.14516","article-title":"Influence of competing risks on estimating the expected benefit of Warfarin in individuals with atrial fibrillation not currently taking anticoagulants: the anticoagulation and risk factors in atrial fibrillation study","volume":"65","author":"Ashburner","year":"2017","journal-title":"J Am Geriatr Soc"},{"issue":"11","key":"10.1016\/j.ejim.2025.106639_bib0045","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCOUTCOMES.119.006212","article-title":"Net clinical benefit of oral anticoagulation among older adults with atrial fibrillation","volume":"12","author":"Shah","year":"2019","journal-title":"Circ Cardiovasc Qual Outcomes"},{"issue":"6","key":"10.1016\/j.ejim.2025.106639_bib0046","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1016\/j.hrthm.2022.02.022","article-title":"Heart Rhythm Society Atrial Fibrillation Centers of Excellence Study: a survey analysis of stakeholder practices, needs, and barriers","volume":"19","author":"Sandhu","year":"2022","journal-title":"Heart Rhythm"},{"issue":"4","key":"10.1016\/j.ejim.2025.106639_bib0047","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1093\/ehjcvp\/pvaa103","article-title":"Off-label use of reduced dose direct oral factor Xa inhibitors in subjects with atrial fibrillation: a review of clinical evidence","volume":"7","author":"Bo","year":"2021","journal-title":"Eur Heart J Cardiovasc Pharmacother"},{"issue":"1","key":"10.1016\/j.ejim.2025.106639_bib0048","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1089\/rej.2007.0569","article-title":"Development and validation of a multidimensional prognostic index for one-year mortality from comprehensive geriatric assessment in hospitalized older patients","volume":"11","author":"Pilotto","year":"2008","journal-title":"Rejuvenation Res"},{"issue":"7","key":"10.1016\/j.ejim.2025.106639_bib0049","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.1111\/jgs.14221","article-title":"Warfarin treatment and all-cause mortality in community-dwelling older adults with atrial fibrillation: a retrospective observational study","volume":"64","author":"Pilotto","year":"2016","journal-title":"J Am Geriatr Soc"},{"issue":"4","key":"10.1016\/j.ejim.2025.106639_bib0050","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1093\/ageing\/afab006","article-title":"A classification tree to assist with routine scoring of the Clinical Frailty Scale","volume":"50","author":"Theou","year":"2021","journal-title":"Age Ageing"},{"key":"10.1016\/j.ejim.2025.106639_bib0051","doi-asserted-by":"crossref","unstructured":"Blythe R., White N.M., Brown C., Hillman K., Barnett A.G. Validation of the Clinical Frailty Scale for predicting 90-day mortality in hospitalised older adults screened as at risk of nearing the end of life in Queensland, Australia: a multisite observational study. Published online November 1, 2025. doi:10.1136\/bmjopen-2025-108419.","DOI":"10.1136\/bmjopen-2025-108419"},{"issue":"1","key":"10.1016\/j.ejim.2025.106639_bib0052","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1007\/s40520-019-01168-9","article-title":"The prognostic significance of geriatric syndromes and resources","volume":"32","author":"Meyer","year":"2020","journal-title":"Aging Clin Exp Res"},{"issue":"6","key":"10.1016\/j.ejim.2025.106639_bib0053","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1111\/jgs.17087","article-title":"Long-term individual and population functional outcomes in older adults with atrial fibrillation","volume":"69","author":"Parks","year":"2021","journal-title":"J Am Geriatr Soc"},{"key":"10.1016\/j.ejim.2025.106639_bib0054","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.ijcard.2019.01.071","article-title":"Patients aged 90 years or older with atrial fibrillation treated with oral anticoagulants: a multicentre observational study","volume":"281","author":"Giustozzi","year":"2019","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.ejim.2025.106639_bib0055","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.ijcard.2017.03.149","article-title":"Clinical profile and outcomes in octogenarians with atrial fibrillation: a community-based study in a specific European health care area","volume":"243","author":"Rodr\u00edguez-Ma\u00f1ero","year":"2017","journal-title":"Int J Cardiol"},{"issue":"11","key":"10.1016\/j.ejim.2025.106639_bib0056","doi-asserted-by":"crossref","first-page":"afad216","DOI":"10.1093\/ageing\/afad216","article-title":"Frailty and anticoagulants in older subjects with atrial fibrillation: the EUROSAF study","volume":"52","author":"Pilotto","year":"2023","journal-title":"Age Ageing"},{"key":"10.1016\/j.ejim.2025.106639_bib0057","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.ejim.2023.10.010","article-title":"Anticoagulation in atrial fibrillation. A large real-world update","volume":"121","author":"Bo","year":"2024","journal-title":"Eur J Intern Med"},{"issue":"3","key":"10.1016\/j.ejim.2025.106639_bib0058","doi-asserted-by":"crossref","first-page":"469","DOI":"10.3390\/jpm12030469","article-title":"Use and prescription of direct oral anticoagulants in older and frail patients with atrial fibrillation: a multidisciplinary consensus document","volume":"12","author":"Proietti","year":"2022","journal-title":"J Pers Med"},{"issue":"24","key":"10.1016\/j.ejim.2025.106639_bib0059","doi-asserted-by":"crossref","first-page":"7423","DOI":"10.3390\/jcm11247423","article-title":"Oral anticoagulant use and appropriateness in elderly patients with atrial fibrillation in complex clinical conditions: a convenience study","volume":"11","author":"Bonanad","year":"2022","journal-title":"J Clin Med"}],"container-title":["European Journal of Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0953620525005163?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0953620525005163?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,12]],"date-time":"2026-04-12T19:17:38Z","timestamp":1776021458000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0953620525005163"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":59,"alternative-id":["S0953620525005163"],"URL":"https:\/\/doi.org\/10.1016\/j.ejim.2025.106639","relation":{},"ISSN":["0953-6205"],"issn-type":[{"value":"0953-6205","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Oral anticoagulant nonprescription at discharge in geriatric patients with atrial fibrillation and reduced expected survival","name":"articletitle","label":"Article Title"},{"value":"European Journal of Internal Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejim.2025.106639","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 European Federation of Internal Medicine. Published by Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"106639"}}